ABT-263 crystalline forms and solvates for use in treating Bcl-2 protein related diseases

Details for Australian Patent Application No. 2010295717 (hide)

Owner Abbott Laboratories

Inventors Zhang, Geoff G.Z; Brackemeyer, Paul J.; Catron, Nathaniel D.; Borchardt, Thomas B.

Agent Spruson & Ferguson

Pub. Number AU-A-2010295717

PCT Pub. Number WO2011/034934

Priority 61/244,051 20.09.09 US

Filing date 15 September 2010

Wipo publication date 24 March 2011

International Classifications

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 March 2012 PCT application entered the National Phase

  PCT publication WO2011/034934 Priority application(s): WO2011/034934

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010295722-Use of alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion

2010295712-Composition comprising cis1,1,1,4,4,4-hexafluoro-2-butene and trans-1,2-dichloroethylene, apparatus containing same and methods of producing cooling therein